Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature 441, 150 (11 May 2006) | doi:10.1038/441150c; Published online 10 May 2006
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
- More Challenges
- Powered by:
nature jobs
Chocolate Food Technologists
- Nestlé
- Broc, Switzerland
Fellowships
- Brighams and Women's Hospital
- Boston, MA
Allergy test might have avoided drug-trial disaster
John H. Weis1
- Pathology Department, University of Utah School of Medicine, 30 North 1900 East 5C124 SOM, Salt Lake City, Utah 84132, USA
Your News story "Can super-antibody drugs be tamed?" (Nature 440, 855–856; 2006), on the TGN1412 anti-CD28 antibody drug and the fallout from this near-fatal clinical trial, lacks a simple interpretation of the data based on common sense.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Intestinal tumor progression is promoted by decreased apoptosis and dysregulated Wnt signaling in Ceacam1 −/− miceOncogene Original Article
